AB SCIEX, Genedata & LECO Announce Partnership for New Cross-Platform Metabolomics Data Analysis Solution
The technology partnership will deliver a collaborative software system, which will enable metabolomics researchers to comprehensively process and analyze experimental data across different GC/MS and LC/MS platforms
June 27, 2013
Basel, Switzerland
AB SCIEX, Genedata, and LECO announce a technology partnership that will deliver a collaborative software system, which will enable metabolomics researchers to comprehensively process and analyze experimental data across different GC/MS and LC/MS platforms. LECO Corporation, a global leader in accurate mass technologies and GC/MS instrumentation, is offering combined solutions with both AB SCIEX, a global leader in LC/MS technology, and Genedata, a global leader in advanced software solutions for drug discovery and life science research. The companies are collaborating to provide a seamless solution to extract valuable biological information from high fidelity LC and GC data. The solution will give metabolomics researchers the ultimate tool for truly comprehensive metabolomics investigations. The partnership announcement was made at the 9th Annual Conference of the Metabolomics Society (July 1-4).
“The ability to bring data from different vendors and technologies onto a single platform, which can process and merge data for maximum biological inference, is where the industry needs to be to effectively evaluate the entire metabolome,” said Dr. Vladimir V. Tolstikov, Scientist, Tailored Therapeutics of Eli Lilly and Company.
The close collaboration of the three companies has resulted in the latest version of Genedata Expressionist® MSX software, developed for metabolomics experiments performed with LECO and AB SCIEX MS systems. Genedata Expressionist MSX, which is compatible with other data formats and technologies as well, is a comprehensive, end-to-end solution for the analysis of mass spectrometry data generated in metabolomics experiments. The software can be downloaded directly via the Internet for immediate installation.
About AB SCIEX
AB SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company’s global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics, and clinical research. With 30 years of proven innovation, AB SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive, and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information about the company, go to http://www.absciex.com. Follow AB SCIEX on Twitter @ABSCIEX, Facebook, and LinkedIn.
About LECO Corporation
For over 75 years, industries around the world have trusted LECO Corporation to deliver technologically advanced products and solutions. Today, that commitment continues with high-speed/high-resolution Time-of-Flight Mass Spectrometry (TOFMS) as well as comprehensive two-dimensional gas chromatography (GCxGC), all featuring easy-to-use ChromaTOF® operating software. Product lines also include high-quality analytical instrumentation, metallography and optical equipment, and consumables. LECO currently has over 30 subsidiaries worldwide, in countries such as the United Kingdom, Australia, Sweden, Canada, and Mexico, with additional distributors authorized to sell or service LECO products to the rest of the world. For more information, visit http://www.leco.com, or follow us on Twitter @LECOCorp, and LinkedIn.
The ability to bring data from different vendors and technologies onto a single platform is where the industry needs to be to effectively evaluate the entire metabolome
Dr. Vladimir V. Tolstikov
Scientist, Tailored Therapeutics, Eli Lilly and Company